Find a Doctor
888-321-DOCS
expand
Multimedia-banner

FDA Issues Warning on Controversial MS Treatment (Health.com)

Source: Health.com
By Robert Preidt


Dr. Karen Blitz-Shabbir,  director of the Multiple Sclerosis Center at Cushing Neuroscience Institute, discusses the need for caution regarding a new, potentially dangerous treatment for MS.

Read the full story.

top